Testing the Gravitostat in Humans: the Impact of a Weighted Vest in Patients Post Bariatric Surgery on Fat-free Mass Retention and Weight Loss
The trial, sponsored by University College Dublin, aims to explore the impact of a weighted vest on fat-free mass retention and weight loss in patients post-bariatric surgery. Given the rising prevalence of obesity and the increasing number of bariatric surgeries performed globally, successful outcomes from this study could position the findings as a novel adjunctive therapy in weight management. The market for obesity treatments is substantial, with a growing demand for effective post-operative care solutions. However, the trial's suspension due to funding issues raises concerns regarding its viability and the potential for future commercialization. Competitors in the obesity management space may include pharmaceutical interventions and other non-invasive devices, necessitating a thorough competitive analysis.
Indication: Obesity
Modality: medical device
Target: Gravitostat mechanism related to fat mass homeostasis and weight control in post-bariatric surgery patients.
Sponsor: University College Dublin
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 03, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Gravitostat mechanism related to fat mass homeostasis and weight control in post-bariatric surgery patients.
View original source fields
Condition raw: Obesity
Condition normalized: Obesity
Modality raw: medical device
Modality normalized: medical device
Target raw: Gravitostat mechanism related to fat mass homeostasis and weight control in post-bariatric surgery patients.
Target normalized: Gravitostat mechanism related to fat mass homeostasis and weight control in post-bariatric surgery patients.